Bipolar I disorder

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)

Bipolar adolescents with comorbid ADHD were initially slower to improve in (hypo)manic symptoms, with more severe symptoms at 3 months compared to those without ADHD.

Effect: decline; F(6,500)=2.22 (ADHD x time interaction)